Top Authors

• Most frequent coverage on MOGN

• 
  Alan Brochstein (711 followers)

  • Cancer Stocks Finish a Tough Quarter (Mon, Oct 1)
  • Cancer Stocks: Lagging Again (Mon, Jul 16)
  • Cancer Stocks: Tracking the Market (Mon, Jul 9)

  More by Alan Brochstein on MOGN »
• 
  Centient Biotech Investor (10 followers)

  • Biotech Stocks: InterMune Retrenches (Thu, Mar 22)
  • Biotech Day In Review: Another Setback for Acomplia from Sanofi-Aventis (Wed, Feb 14)
  • Biotech Stocks Day-In-Review: Adherex Buys Out GSK Option (Fri, Jan 19)

  More by Centient Biotech Investor on MOGN »
• 
  Steven Towns (29 followers)

  • Japan's Eisai to Acquire MGI Pharma for $3.9B (Mon, Dec 10)

  More by Steven Towns on MOGN »

• Most followed authors on MOGN

• 
  Don Dion (2775 followers)

  • PowerShares Dynamic Pharmaceuticals ETF Faces Host of Challenges (Fri, Jan 25)

  More by Don Dion on MOGN »
• 
  Mike Havrilla (1949 followers)

  • A Super(Gen) Play on Cancer Biotech Consolidation (Sun, Dec 16)

  More by Mike Havrilla on MOGN »
• 
  Alan Brochstein (711 followers)

  • Cancer Stocks Finish a Tough Quarter (Mon, Oct 1)
  • Cancer Stocks: Lagging Again (Mon, Jul 16)
  • Cancer Stocks: Tracking the Market (Mon, Jul 9)

  More by Alan Brochstein on MOGN »

• Newest authors on MOGN

• 
  Don Dion (2775 followers)

  • PowerShares Dynamic Pharmaceuticals ETF Faces Host of Challenges (Fri, Jan 25)

  More by Don Dion on MOGN »
• 
  Mike Havrilla (1949 followers)

  • A Super(Gen) Play on Cancer Biotech Consolidation (Sun, Dec 16)

  More by Mike Havrilla on MOGN »
• 
  Alan Brochstein (711 followers)

  • Cancer Stocks Finish a Tough Quarter (Mon, Oct 1)
  • Cancer Stocks: Lagging Again (Mon, Jul 16)
  • Cancer Stocks: Tracking the Market (Mon, Jul 9)

  More by Alan Brochstein on MOGN »

• Most commented on MOGN

• 
  Alan Brochstein (711 followers)

  • Cancer Stocks Finish a Tough Quarter (Mon, Oct 1)
  • Cancer Stocks: Lagging Again (Mon, Jul 16)
  • Cancer Stocks: Tracking the Market (Mon, Jul 9)

  More by Alan Brochstein on MOGN »
• 
  Mike Havrilla (1949 followers)

  • A Super(Gen) Play on Cancer Biotech Consolidation (Sun, Dec 16)

  More by Mike Havrilla on MOGN »
• 
  Centient Biotech Investor (10 followers)

  • Biotech Stocks: InterMune Retrenches (Thu, Mar 22)
  • Biotech Day In Review: Another Setback for Acomplia from Sanofi-Aventis (Wed, Feb 14)
  • Biotech Stocks Day-In-Review: Adherex Buys Out GSK Option (Fri, Jan 19)

  More by Centient Biotech Investor on MOGN »